Client
- Name
- BIOGEN
- Location
- District of Columbia · United States of America
Registrant
- Firm
- BIOGEN
- Location
- WASHINGTON, District of Columbia, United States of America
Lobbying activities
6 issuesHealth Issues
Discussions regarding drug pricing and supply chain issues, rare diseases, gene therapy and value based arrangements; biosimilar support; Alzheimer's policy, screening and diagnosis, PET scan coverage and reimbursement, and dementia care Inflation Reduction Act implementation (P.L.117-1769), including provisions related to corporate taxes, Medicare, research and development, and prescription drug pricing The Mental Health Professionals Workforce Shortage Loan Repayment Act S.1214, RARE Act Issues related to ALS
LobbyistsJOHN RAYMOND GIBSON · JONATHAN CAUSEY · TYLER HANSON · DANIEL HARDER · mx ALI LAKHANI · ms KATHLEEN KONKA
TargetedSENATE · HOUSE OF REPRESENTATIVES · Centers For Medicare and Medicaid Services (CMS)
Medicare/Medicaid
Drug cost and pricing policy issues Issues related to the 340B program
LobbyistsJONATHAN CAUSEY · DANIEL HARDER · ms KATHLEEN KONKA
TargetedSENATE · HOUSE OF REPRESENTATIVES · Centers For Medicare and Medicaid Services (CMS)
Pharmacy
Drug cost and pricing policy S.1967, PBM Act S.1542, DRUG Act H.R.5539, ORPHAN Cures Act Discussions regarding pharmaceutical issues related to supply chain S.113, Prescription Pricing for the People Act of 2023 H.R.830, HELP Copays Act H.R.485, Protecting Health Care for All Patients Act